Investors need to pay close attention to Allegro MicroSystems (ALGM) stock based on the movements in the options market lately.

GM plans to invest $888 million in the Tonawanda Propulsion plant to build next-generation V-8s with better fuel efficiency and performance.

Intuitive Surgical or Medtronic -- who leads the future of robotic surgery? Here's a comparative analysis to help you make a smart choice for 2025.

Mobile payments surge as GDOT, MQ, VYX and FOUR roll out innovations to boost volume, streamline checkout, and expand global reach.

CRM outpaces ADBE with stronger AI growth, better valuation, and steadier earnings, giving CRM the edge in cloud software stocks.

NEW YORK, NY / ACCESS Newswire / May 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Travere Therapeutics, Inc. ("Travere Therapeutics, Inc.") (NASDAQ:TVTX) concerning possible violations of federal securities laws. Travere issued a press release on May 15, 2025, disclosing that the U.S. Food and Drug Administration ("FDA") "has indicated that it is currently planning to hold an advisory committee meeting to discuss" the Company's "supplemental New Drug Application (sNDA) for traditional approval of FILSPARI (sparsentan) for the treatment of focal segmental glomerulosclerosis (FSGS).

NEW YORK, NY / ACCESS Newswire / May 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Meta Platforms, Inc. ("Meta Platforms, Inc.") (NASDAQ:META) concerning possible violations of federal securities laws. The Wall Street Journal published an article on May 15, 2025, entitled "Meta Is Delaying the Rollout of Its Flagship AI Model.

TAMPA, Fla.--(BUSINESS WIRE)--The Baldwin Group, in collaboration with Nasdaq, Inc. (“Nasdaq”), today released its 2025 Directors & Officers (D&O) Benchmarking Report, offering one of the most comprehensive views to date of D&O insurance trends across public companies by industry and market capitalization. Now in its fourth year, the report confirms a continuing decline in premium rates and retentions—but also reveals a growing disconnect between what companies are buying and what t.

Hims & Hers Health shows strong growth in subscribers, revenue, and profitability, driven by expanding offerings and strategic partnerships, especially in weight loss and dermatology. HIMS posted stellar Q1 FY 2025: Revenue +110%, EBITDA +181%, EPS +300%. Growth fueled by ~2.4M subscribers and $84 average monthly revenue per user. Management's ambitious 2030 strategy leverages AI, new specialties, and global expansion, aiming for significant top-line and EPS growth.

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

Evaluate the expected performance of Ollie's Bargain Outlet (OLLI) for the quarter ended April 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Evaluate the expected performance of HealthEquity (HQY) for the quarter ended April 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Beyond analysts' top -and-bottom-line estimates for Dollar General (DG), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended April 2025.

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Donaldson (DCI), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended April 2025.

Get a deeper insight into the potential performance of Signet (SIG) for the quarter ended April 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Beyond analysts' top -and-bottom-line estimates for Hewlett Packard Enterprise (HPE), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended April 2025.

Beyond analysts' top -and-bottom-line estimates for CrowdStrike (CRWD), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended April 2025.

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Guidewire Software (GWRE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended April 2025.

China-based EV company NIO Inc. NIO is slated to release first-quarter 2025 results on June 3, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at a loss of 22 cents a share on revenues of $1.71 billion.

BMY slides 20.7% in 3 months despite strong Q1 and raised outlook, as generic pressure and pipeline setbacks weigh on investor sentiment.